CA2422424A1 - Compositions pharmaceutiques pour administration par voie rectale et vaginale - Google Patents

Compositions pharmaceutiques pour administration par voie rectale et vaginale Download PDF

Info

Publication number
CA2422424A1
CA2422424A1 CA002422424A CA2422424A CA2422424A1 CA 2422424 A1 CA2422424 A1 CA 2422424A1 CA 002422424 A CA002422424 A CA 002422424A CA 2422424 A CA2422424 A CA 2422424A CA 2422424 A1 CA2422424 A1 CA 2422424A1
Authority
CA
Canada
Prior art keywords
dosage form
active ingredient
amount
effervescent
target area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002422424A
Other languages
English (en)
Other versions
CA2422424C (fr
Inventor
S. Indiran Pather
Joseph R. Robinson
Jonathan D. Eichman
Rajendra K. Khankari
John Hontz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cima Labs Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2422424A1 publication Critical patent/CA2422424A1/fr
Application granted granted Critical
Publication of CA2422424C publication Critical patent/CA2422424C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques comprenant des formes posologiques pouvant être administrées par voie rectale et vaginale, qui contiennent des agents effervescents comme activateurs de pénétration de médicaments. L'effervescence se produit dans le rectum ou le vagin après administration de la forme posologique ou au bout d'une durée prédéterminée consécutive à l'administration. Les agents effervescents peuvent être utilisés seuls ou en combinaison avec une matière de réglage de pH qui active davantage la dissolution et l'absorption de l'ingrédient actif.
CA002422424A 2000-09-19 2000-09-19 Compositions pharmaceutiques pour administration par voie rectale et vaginale Expired - Fee Related CA2422424C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/025634 WO2002024170A1 (fr) 2000-09-19 2000-09-19 Compositions pharmaceutiques pour administration par voie rectale et vaginale

Publications (2)

Publication Number Publication Date
CA2422424A1 true CA2422424A1 (fr) 2002-03-28
CA2422424C CA2422424C (fr) 2009-12-01

Family

ID=21741785

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002422424A Expired - Fee Related CA2422424C (fr) 2000-09-19 2000-09-19 Compositions pharmaceutiques pour administration par voie rectale et vaginale

Country Status (5)

Country Link
EP (1) EP1318790A4 (fr)
JP (1) JP2004509142A (fr)
AU (1) AU7384700A (fr)
CA (1) CA2422424C (fr)
WO (1) WO2002024170A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1872775A1 (fr) 2006-06-29 2008-01-02 Polichem S.A. Emploi d'une matrice hydrophile contenant un dérivé polyacrylique, un éther de cellulose et un désintégrant, pour la production d'un médicament pour le traitement des troubles génitales d'une femme

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1212704A (en) * 1967-11-21 1970-11-18 Prodotti Antibiotici Spa Vaginal suppositories
US3888976A (en) * 1972-09-21 1975-06-10 William P Mlkvy Zinc and strontium ion containing effervescent mouthwash tablet
NL7302521A (en) * 1973-02-23 1974-08-27 Foaming, effervescent capsules - contg. therapeutic agents for rectal and vaginal use
JPS58152809A (ja) * 1982-03-05 1983-09-10 Eisai Co Ltd 安定な発泡性「膣」坐剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE4139883A1 (de) * 1991-11-29 1993-06-03 Michael Prof Dr Dittgen Verfahren zur herstellung bioadhaesiver arzneimittel
GB9523136D0 (en) * 1995-11-11 1996-01-10 Procter & Gamble Silicone-containing powders
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
EP1104290B1 (fr) * 1998-08-13 2010-03-31 Cima Labs Inc. Microemulsions comme formes pharmaceutiques solides destinees a une administration orale

Also Published As

Publication number Publication date
CA2422424C (fr) 2009-12-01
AU2000273847B2 (en) 2006-09-14
EP1318790A4 (fr) 2006-02-01
JP2004509142A (ja) 2004-03-25
AU7384700A (en) 2002-04-02
EP1318790A1 (fr) 2003-06-18
WO2002024170A1 (fr) 2002-03-28

Similar Documents

Publication Publication Date Title
US5112616A (en) Fast dissolving buccal tablet
US5073374A (en) Fast dissolving buccal tablet
KR100874876B1 (ko) 맛을 마스킹한 필름상 또는 웨이퍼상 약제
US6576250B1 (en) Pharmaceutical compositions for rectal and vaginal administration
JP4815084B2 (ja) 固溶体を用いる経口経粘膜薬剤投与形態
ES2321589T3 (es) Composicion farmaceutica antiabuso que contiene capsaicina.
ES2330873T3 (es) Composicion para dosificacion oral de liberacion prolongada.
US6087362A (en) Apomorphine and sildenafil composition
ATE347879T1 (de) Transdermale pharmazeutische zusammensetzung zur wirkstoffverabreichung
JP2004534839A5 (fr)
JP2009185078A (ja) 動物用及びヒト用医薬における活性物質の投与用の、粘膜接着性を有し、崩壊可能な医薬品調合剤
BRPI0608505A2 (pt) comprimido sublingual revestido
CA2470703A1 (fr) Produits pharmaceutiques oraux renfermant 17.beta.-estradiol-3-alcanoate inferieur, procede d'administration et de preparation associes
KR20100102632A (ko) 경점막 흡수용 페닐에프린 약제학적 제형 및 조성물
WO2020180608A1 (fr) Préparations de comprimé de dipivéfrine à désintégration buccale
US20150283066A1 (en) Vaginal danazol combined with non steroidal anti inflammatory drugs (nsaids) compositions
US20030118645A1 (en) Pharmaceutical compositions for rectal and vaginal administration
CA2422424A1 (fr) Compositions pharmaceutiques pour administration par voie rectale et vaginale
ES2235523T3 (es) Empleo de esteres de testosterona y/o de testoterona para la produccion de sistemas bioadhesivos de aplicacion bucal con accion temporizada del medicamento.
AU2000273847C1 (en) Pharmaceutical compositions for rectal and vaginal administration
GB2394415A (en) Buccal tablet
AU2000273847A1 (en) Pharmaceutical compositions for rectal and vaginal administration
Alur et al. Polysaccharide-Based Mucoadhesive Buccal Tablets

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160919